13 July 2023
Évry, France, Thursday July (…) »
24 April 2023
Evry, France, april 24th 2023, 6 pm – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), IntegraGen, a company specializing in the decryption of the (…) »
13 January 2023
EVRY, FRANCE, FRIDAY JANUARY 13TH 2023, 7.30AM CET – IntegraGen (FR0010908723 – ALINT), an OncoDNA Group company specializing in the decryption of (…) »
18 October 2022
EVRY, FRANCE, TUESDAY OCTOBER 18TH 2022, 7.30AM – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), IntegraGen, a company specializing in the decryption (…) »
13 July 2022
Evry, France, Wednesday July 13th 2022, 7.30am – IntegraGen (FR0010908723 – ALINT ), an OncoDNA Group company specializing in the decryption of the human genome which performs (…) »
29 April 2022
Évry, France, april 29TH 2022 – 6.00pm (…) »
20 January 2022
IntegraGen and BIOASTER have been collaborating for several years in the context of genomic and transcriptomic analyses. Driven by a desire to strengthen this relationship further, the two entities have entered into a long-term partnership agreement (Master Research Service Agreement). This agreement will facilitate and accelerate exchanges between (…) »
19 January 2022
Rejoignez-nous lors du 33ème séminaire de génétique clinique les 2 et 3 février 2023 à Angers. Thomas Bolzec et Mira Ayadi vous attendent avec plaisir sur notre stand pour discuter de vos projets de génomique. N’hésitez pas à les contacter pour prendre rendez-vous : services@integragen.com
14 January 2022
EVRY, FRANCE, FRIDAY 14 JANUARY 2021, 7.30 – IntegraGen (FR0010908723 – ALINT – Eligible PEA PME), an OncoDNA group (…) »
24 December 2021
Ditsa Keren is a technology blogger and entrepreneur with a strong passion for biology, ecology and the environment. She spoke to our CEO Bernard Courtieu to hear about the latest advancements in precision medicine and the promise we bring to oncology physicians and researchers.
